These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 21762992)
21. Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery. Maca SM; Amon M; Findl O; Kahraman G; Barisani-Asenbauer T Am J Ophthalmol; 2010 May; 149(5):777-84. PubMed ID: 20152959 [TBL] [Abstract][Full Text] [Related]
22. Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery. Lane SS; Holland EJ J Cataract Refract Surg; 2013 Feb; 39(2):168-73. PubMed ID: 23232255 [TBL] [Abstract][Full Text] [Related]
24. Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification. Sahu S; Ram J; Bansal R; Pandav SS; Gupta A J Cataract Refract Surg; 2015 Oct; 41(10):2043-8. PubMed ID: 26703278 [TBL] [Abstract][Full Text] [Related]
25. Comparison of topically applied flurbiprofen or bromfenac ophthalmic solution on post-operative ocular hypertension in canine patients following cataract surgery. Lu J; English R; Nadelstein B; Weigt A; Berdoulay A; Binder D; Ngan E Vet Ophthalmol; 2017 Mar; 20(2):107-113. PubMed ID: 26990912 [TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of indomethacin 0.1% eye drops compared with ketorolac 0.5% eye drops in the management of ocular inflammation after cataract surgery. Weber M; Kodjikian L; Kruse FE; Zagorski Z; Allaire CM Acta Ophthalmol; 2013 Feb; 91(1):e15-21. PubMed ID: 22970738 [TBL] [Abstract][Full Text] [Related]
27. Twice-daily, preservative-free ketorolac 0.45% for treatment of inflammation and pain after cataract surgery. Donnenfeld ED; Nichamin LD; Hardten DR; Raizman MB; Trattler W; Rajpal RK; Alpern LM; Felix C; Bradford RR; Villanueva L; Hollander DA; Schiffman RM Am J Ophthalmol; 2011 Mar; 151(3):420-6.e1. PubMed ID: 21145532 [TBL] [Abstract][Full Text] [Related]
28. A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain. Southworth S; Peters J; Rock A; Pavliv L Clin Ther; 2009 Sep; 31(9):1922-35. PubMed ID: 19843482 [TBL] [Abstract][Full Text] [Related]
37. Comparison of the analgesic efficacy and safety of nepafenac ophthalmic suspension compared with diclofenac ophthalmic solution for ocular pain and photophobia after excimer laser surgery: a phase II, randomized, double-masked trial. Colin J; Paquette B Clin Ther; 2006 Apr; 28(4):527-36. PubMed ID: 16750464 [TBL] [Abstract][Full Text] [Related]
38. Comparison of the Efficacy of Dexamethasone, Nepafenac, and Bromfenac for Preventing Pseudophakic Cystoid Macular Edema: an Open-label, Prospective, Randomized Controlled Trial. Campa C; Salsini G; Perri P Curr Eye Res; 2018 Mar; 43(3):362-367. PubMed ID: 29120255 [TBL] [Abstract][Full Text] [Related]
39. Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days. Riff DS; Duckor S; Gottlieb I; Diamond E; Soulier S; Raymond G; Boesing SE Clin Ther; 2009 Oct; 31(10):2072-85. PubMed ID: 19922878 [TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of bromfenac for the treatment of corneal ulcer pain. Schechter BA; Trattler W Adv Ther; 2010 Oct; 27(10):756-61. PubMed ID: 20845001 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]